---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-377073"
form_type: "8-K"
ticker: "JAZZ"
cik: "0001232524"
company_name: "Jazz Pharmaceuticals plc"
filed_at: "2026-08-31T21:21:41+00:00"
generated_at: "2026-08-31T21:24:44.573174+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Jazz closes $1.25B exchangeable notes offering; repurchases $225M shares

## Summary
- Completed $1.25B 1.875% exchangeable senior notes due 2032, including full $150M greenshoe exercise.
- Net proceeds estimated at ~$1,226.4M; intended for general corporate purposes.
- Initial exchange rate 2.8150 shares per $1,000 principal; exchange price ~$355.24 (42.5% premium).
- Concurrently repurchased ~$225M of ordinary shares at $249.29 via private transactions.
- Notes mature Sept 15, 2032; fully and unconditionally guaranteed by Jazz on senior unsecured basis.

## SEC filing metadata
- accession: 0001193125-26-377073
- form_type: 8-K
- ticker: JAZZ
- cik: 0001232524
- company_name: Jazz Pharmaceuticals plc
- filed_at: 2026-08-31T21:21:41+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1232524/000119312526377073/0001193125-26-377073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1232524/000119312526377073/d127542d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-377073
- JSON: https://secwatch.observer/filing/0001193125-26-377073.json
- Plain text: https://secwatch.observer/filing/0001193125-26-377073.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.